ArticleBlood2016

Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells.

Bin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.